Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
This slideshow reviews drug information for KEYTRUDA (pembrolizumab), indicated for head and neck cancer.
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide 10: Use in Specific Populations
Slide 13: Clinical Pharmacology
Slide 17: Warnings and Precautions
Slide 22: Clinical Safety and Efficacy
Slide 28: Drug Storage and Supply
Slide 30: References